Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan-Based Therapies for H. Pylori Eradication
NCT06977841Completed
- Sponsor
- Zhongshan Hospital (Xiamen), Fudan University
- Start
- Jun 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of tegoprazan in Helicobacter pylori infection (4 arms), sponsored by Zhongshan Hospital (Xiamen), Fudan University. Primary endpoint: Helicobacter pylori eradication rate at 44 days. Started Jun 2025; status: completed.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT06977841.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06977841.